an advanced cell technology blog

ACT's Company Blog.

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

  • Company Blog
  • ACTC.OBTerms of use
  • Contact

These are the posts from May 2011

May 17, 2011
Posted by Admin

ACT Announces Oregon Health & Science University As Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration

The company issued the following release today.
ACT Announces Oregon Health & Science University As Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration
Institutional Review Board (IRB) Approves Phase 1/2 Trial for Stargardt’s Macular Dystrophy (SMD)
MARLBOROUGH, Mass. — May 16, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), [...]

No Comments

Posted Under Uncategorized

May 9, 2011
Posted by Admin

Advanced Cell Technology Announces 2011 First Quarter Results

The company issued the following release today.
Advanced Cell Technology Announces 2011 First Quarter Results
MARLBOROUGH, Mass. — May 9, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations [...]

No Comments

Posted Under Stock Talk

May 5, 2011
Posted by Admin

ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London

The company issued the following release today.
ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London
Mr. Rabin Will Discuss Two Upcoming Clinical Trials Using Human Embryonic Stem Cell (hESC)-Derived Retinal Pigment Epithelial (RPE) Cells to Treat Macular Degeneration
MARLBOROUGH, Mass. — May 5, 2011 – Advanced Cell [...]

No Comments

Posted Under Uncategorized

May 2, 2011
Posted by Admin

Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for Continued Federal Funding of Embryonic Stem Cell Research

The company issued the following press release today.
Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for Continued Federal Funding of Embryonic Stem Cell Research
Ruling Could Provide Tremendous Boost to Regenerative Medicine Industry
MARLBOROUGH, Mass. — May 2, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today [...]

No Comments

Posted Under ACT Events Uncategorized


     

    ACT Publishes...

    Uncategorized

      

    Scientific...

    Uncategorized

      

    ACT and Roslin...

    Uncategorized

    Gary Rabin Chairman's Blog: Timing and Pace of Our Clinical Trials http://t.co/I6YfXPDc #SMD #DryAMD #hESCs

    follow me on
    twitter

    ACTC.OB Stock Quote


    Advanced Cell Tecchart +0.00%

    2012-02-22 15:59

  • Categories

    • ACT Events
    • Biotechnology
      • Regenerative
    • human trials
    • Stock Talk
      • Governance
      • Reports
    • Uncategorized

  • Archives

    • 2012
      • January
    • 2011
      • January
      • February
      • March
      • April
      • May
      • June
      • October
    • 2010
      • January
      • February
      • March
      • April
      • May
      • June
      • July
      • August
      • September
      • November
      • December

    • Facebook

    ACT Links

    • Biotech Investors Network
    • Medical Technology
    • Patient Support Group
    • LinkedIn Company page
    • Facebook Company page
    • Twitter Company page
    • Google Groups
    • Chairmans blog RSS feed

Powered by WordPress: this website is official and sanctioned by Advanced Cell Technology.